COVID-⁠19 Switzerland

The graph shows the share of vaccinated people by canton of residence for the selected age group. People who are resident outside Switzerland and the Principality of Liechtenstein, and those whose residence is not known, are shown separately.
The age groups presented correspond to the COVID-⁠19 vaccination strategy.

The data published here is based on information provided to us regularly by the cantons and the Principality of Liechtenstein. We publish the numbers on the following day. Therefore, they may differ from the numbers communicated by the cantons and Liechtenstein. The figures cover vaccines from all manufacturers.

Three vaccines for preventing COVID-⁠19 are authorised in Switzerland and Liechtenstein. People are deemed to be fully vaccinated if they have received two doses of Moderna (Spikevax®) or Pfizer/BioNTech (Comirnaty®) vaccine, or one dose of these vaccines after a proven infection with SARS-⁠⁠CoV2 (FOPH/Federal Vaccination Commission vaccination recommendation). Only one dose of the Johnson & Johnson (Covid-⁠⁠19 Vaccine Janssen®) vaccine is required.
A booster vaccination with an mRNA vaccine from Moderna (Spikevax®) or Pfizer/BioNTech (Comirnaty®) is recommended from four months following full vaccination (primary course of vaccination) for anyone aged 16 and over.
Fully vaccinated people who receive a booster vaccination in accordance with the FOPH/Federal Vaccination Commission vaccination recommendation are presented separately. The share of fully vaccinated people relates to the total population or the age group in question.
Vaccinated people are allocated to the canton in which they live (canton of residence).

The cantons and the Principality of Liechtenstein provide us with the data via a secure electronic channel. They are sent in the form of anonymised individual data.